Article Text
PDFControversy
Expectations regarding cognitive enhancement create substantial challenges
Abstract
A recent discussion on cognitive enhancers has caused some controversy in the ethics and neuroscience fields by coming out in favour of making neuropharmaceuticals with enhancing properties available for general consumption. We highlight in this brief commentary why concerns regarding efficacy and safety, demands on resources, and public health are substantive enough to warrant serious reconsideration before pharmaceutical performance enhancement can be widely supported.
Statistics from Altmetric.com
Linked Articles
- The concise argument
Read the full text or download the PDF:
Other content recommended for you
- Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology
- Drug use in English professional football
- Non-medical use of prescription pain relievers among high school students in China: a multilevel analysis
- Cross-sectional study on influence of the family environment on the lifetime non-medical use of prescription drugs among Chinese adolescents in Guangdong: an analysis of sex differences
- Multimorbidity, psychoactive substance use and psychological distress among acute medically ill patients: a cross-sectional study
- Alcohol and other drug use among Belgian workers and job-related consequences
- UK survey of non-medical use of prescription drugs (NMURx) as a valuable source of general population illicit drug use data
- Predictors of controlled prescription drug non-medical and lifetime use among patients accessing public mental health services in Uganda: a cross-sectional study
- Comparison and validation of screening tools for substance use in pregnancy: a cross-sectional study conducted in Maryland prenatal clinics
- Prescription drugs with potential for misuse: protocol for a multi-indicator analysis of supply, detection and the associated health burden in Ireland between 2010 and 2020